Mixed Dyslipidemia
📧 Sign up to get email alerts when something new happens for Mixed Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 4]
Phase 4 clinical trial in India evaluating the safety and effectiveness of inclisiran sodium for primary hypercholesterolemia or mixed dysli…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A [Phase 3]
A Phase 3 trial evaluated the combination DW5421A/DW5421B versus DW5421A monotherapy for primary hypercholesterolemia and mixed dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia [Phase 2]
Phase 2 study evaluating Plozasiran (ARO-APOC3) in adults with mixed dyslipidemia has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients
A completed real-world study assessing the effectiveness of inclisiran and PCSK9 monoclonal antibodies in Chinese adults with hypercholester…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and the effect of food on DW5124 and DW5124-R in healthy volunteers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia [Phase 2]
This update reports the completion of a Phase II study evaluating the safety and efficacy of SAL003 in combination with atorvastatin for hyp…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan [Phase 4]
This Phase 4 clinical trial evaluating the effectiveness and safety of bempedoic acid in adults with primary hypercholesterolemia or mixed d…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia [Phase 3]
A multicenter, randomized Phase III trial evaluated SAL003 in combination with statin therapy for hyperlipidemia and mixed dyslipidemia and …
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: The Food Effect on PK Characteristics and Safety Profiles of PA-111 [Phase 1]
Phase 1 clinical trial update evaluating the effect of food on the pharmacokinetics and safety of PA-111 in patients with Mixed Dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol. [Phase 3]
Phase 3 trial evaluating inclisiran as monotherapy in Chinese adults with elevated LDL-C and low-to-moderate ASCVD risk shows efficacy and s…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector
This entry reports the completion of a non-interventional study evaluating monthly 300 mg alirocumab (PRALUENT) administered using the SYDNE…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
A completed real-world study evaluating Inclisiran in Chinese adults with primary hypercholesterolemia or mixed dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of ARO-ANG3 in Adults With Mixed Dyslipidemia [Phase 2]
Phase 2 study of ARO-ANG3 in adults with mixed dyslipidemia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Bezafibrate Plus Berberine in Mixed Dyslipidemia [Phase 3]
Phase 3 trial of bezafibrate plus berberine in mixed dyslipidemia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia [Phase 3]
Phase 3 trial in Chinese participants evaluating evolocumab added to background statin therapy for primary hypercholesterolemia and mixed dy…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia [Phase 3]
Open-label extension study of evolocumab in adults with hyperlipidemia and mixed dyslipidemia completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia [Phase 3]
Phase 3 trial evaluating evolocumab in combination with statin therapy in adults with diabetes and hyperlipidemia or mixed dyslipidemia; com…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia [Phase 3]
Phase 3 trial evaluating evolocumab in diabetic adults with hypercholesterolemia or mixed dyslipidemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events [Phase 3]
Phase 3 randomized trial evaluating bococizumab in subjects with hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events has c…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia [Phase 3]
This entry notes the completion of a Phase 3 trial evaluating different doses of fluvastatin for efficacy and safety in adults with mixed dy…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody [Phase 3]
Phase 3 trial evaluating effects on lipoprotein metabolism from PCSK9 inhibition using a monoclonal antibody in primary hyperlipidemia and m…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143) [Phase 3]
A Phase 3 trial evaluating an extended-release combination tablet of niacin, laropiprant, and simvastatin in individuals with primary hyperc…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: MK-0524B Lipid Study (MK-0524B-063) [Phase 3]
A Phase 3 clinical trial of MK-0524B for primary hypercholesterolemia and mixed dyslipidemia has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab [Phase 1]
Phase 1 pharmacokinetic study assessing the impact of severe renal impairment and dialysis on evolocumab.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen [Phase 3]
Phase 3 trial assessing in-home administration of evolocumab (AMG 145) using automated mini-doser or prefilled autoinjector/pen in patients …